Pieris Pharmaceuticals Inc (PIRS)
13.60
-2.53
(-15.69%)
USD |
NASDAQ |
Dec 13, 16:00
13.35
-0.25
(-1.84%)
After-Hours: 20:00
Pieris Pharmaceuticals Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 55.08M |
Cyclo Therapeutics Inc | 7.999M |
NovaBay Pharmaceuticals Inc | 2.089M |
Palatin Technologies Inc | -0.127M |
iBio Inc | -0.162M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 0.146M |
Cash from Investing (Quarterly) | 0.142M |
Free Cash Flow | -28.00M |
Free Cash Flow Per Share (Quarterly) | 0.1106 |